Dysmenorrhea Treatment Market Key Vendors, Segment, Growth Opportunities by 2016 to 2030
Market Overview
The global Dysmenorrhea
Treatment Market is expected to cross USD 6,312.88 million by 2030 at a
CAGR of 8.20% during the forecast period 2022-2030.
Recently the outbreak of the Covid-19 pandemic has
globally vastly impacted women's health. The pandemic affected the female
population and made them face an extended period of illness that also inclined
towards the increasing duration of the menstrual cycle, which severely affected
the women and led to several health issues.
Dysmenorrhea is generally classified as menstrual cramps,
which harshly affects women's health. The major factors attributed to
channelizing the Dysmenorrhea Treatment Market. growth are the
rapidly increasing rate of Dysmenorrhea among teenage girls. Due to genetic
disorders, menstrual cramps are also gripping rapid effects among women.
Concerns beholding to the harsh effects and increasing availability of various
products are implied to curb the market's growth. The increasing population of
females and rapidly growing menstrual health issues is developing openings
for Dysmenorrhea Treatment Market.
Key
Players:
key
players in the global dysmenorrhea treatment market— Johnson & Johnson
(US), GlaxoSmithKline PLC (UK), F. Hoffmann-La Roche Ltd (Switzerland), Bayer
AG (Germany), Focus Consumer Healthcare, LLC (US), Novartis AG (Switzerland),
Pfizer, Inc. (US), Reckitt Benckiser Group plc. (UK), Sanofi S.A. (France) and
Viatris Inc. (US) among others.
Market Segmentation:
The Dysmenorrhea
Treatment Market has been segmented based on type, type of
treatment, and end-user.
·
By
type includes primary Dysmenorrhea, which happens before menstrual bleeding women will face recurring
and very painful menstrual cramps. The pain is likely to be high in the back,
lower abdomen, or thigh and mild to severe. It lasts up to 12 to 72
hours. Nauseous, fatigue, diarrhea, and vomiting are some of the symptoms
of primary
Dysmenorrhea. Then comes the secondary
Dysmenorrhea, and It is studied that endometriosis is the leading cause of
secondary Dysmenorrhea among adolescent women.
·
On the
factors of treatment Dysmenorrhea Treatment Market has
been segmented into pain relievers, hormonal therapy, surgery, and others. The
market is dealing well with the medication procedure as the growth of menstrual
problems is a rising rapidly day by day. The Dysmenorrhea Treatment Market is
divided into parts based on end-users, such as hospitals, clinics, research
centers, and others.
·
Other
end-users, such as ambulatory
surgical centers and specialty centers, are also other end-users. In ambulatory
surgical centers, methods can be performed on the same day.
Regional Analysis:
Based on the region, the global Dysmenorrhea Treatment Market has
been fractionated into the Americas, Europe, Asia-Pacific, and the the Middle
East and Africa.
It is subjected that Americas accounted for the biggest
share in the field of Dysmenorrhea
Treatment Market. Due to the increasing number of women
suffering from Dysmenorrhea, the treatment market is strongly holding its pace
rapidly. Along with this, other regions are also developing their need
for Dysmenorrhea Treatment
Market.
Industry News:
·
Recently,
a company known as GlaxoSmithKlinePlC, based in the UK, has involved itself
with Dysmenorrhea Treatment
Market and planning to introduce new medications and
developmental aspects for this serious menstrual issue.
Related Reports:
About US:
Market
Research Future (MRFR) enable customers to unravel the complexity of various industries
through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw
Research Reports (3R), Continuous-Feed Research (CFR), and Market Research
& Consulting Services.
Contact us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99
Hudson Street,5Th Floor, New York,
New
York 10013
Comments
Post a Comment